Evidence for an altered tryptophan metabolism in fibromyalgia

Neurobiology of Disease

Volumn 11, Issue 3, 2002, Pages 434-442

  Schwarz, M J ^a   Offenbaecher, M ^a   Neumeister, A ^b   Ewert, T ^a   Willeit, M ^c   Praschak Rieder, N ^c   Zach, J ^a   Zacherl, M ^a   Lossau, K ^a   Weisser, R ^a   Stucki, G ^a   Ackenheil, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; INTERLEUKIN 6; KYNURENINE; SEROTONIN; TRYPTOPHAN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FIBROMYALGIA; HUMAN; NEUROPATHOLOGY; NOCICEPTION; PAIN ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROTONIN METABOLISM; TRYPTOPHAN METABOLISM;

EID: 0345270013     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0563     Document Type: Article

References (36)

1. Abbott F. V., Etienne P., Franklin K. B., Morgan M. J., Sewitch M. J., Young S. N. Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology (Berl.). 108:1992;60-66.
2. Arnold L. M., Keck P. E., Welge J. A. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics. 41:2000;104-113.
3. Beharka A. A., Meydani M., Wu D., Leka L. S., Meydani A., Meydani S. N. Interleukin-6 production does not increase with age. J. Gerontol. A Biol. Sci. Med. Sci. 56:2001;B81-B88.
4. Bonaccorso S., Lin A., Song C., Verkerk R., Kenis G., Bosmans E., Scharpe S., Vandewoude M., Dossche A., Maes M. Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer's disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT. Aging (Milano.). 10:1998b;316-323.
5. Bonaccorso S., Lin A. H., Verkerk R., van Hunsel F., Libbrecht I., Scharpe S., DeClerck L., Biondi M., Janca A., Maes M. Immune markers in fibromyalgia: Comparison with major depressed patients and normal volunteers. J. Affect. Disord. 48:1998a;75-82.
6. Carpenter L. L., Anderson G. M., Pelton G. H., Gudin J. A., Kirwin P. D., Price L. H., Heninger G. R., McDougle C. J. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology. 19:1998;26-35.
7. Delgado P. L., Charney D. S., Price L. H., Aghajanian G. K., Landis H., Heninger G. R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry. 47:1990;411-418.
8. Dugue B., Leppanen E., Grasbeck R., Benoit D., Esa L., Ralph G. The driving license examination as a stress model: Effects on blood picture, serum cortisol and the production of interleukins in man. Life Sci. 68:2001;1641-1647.
9. Dugue B., Leppanen E. A., Teppo A. M., Fyhrquist F., Grasbeck R. Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortisol. Scand. J. Clin. Lab Invest. 53:1993;555-561.
10. Fishbain D. Evidence-based data on pain relief with antidepressants. Ann. Med. 32:2000;305-316.
11. Goebel M. U., Mills P. J., Irwin M. R., Ziegler M. G. Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: Differential effects and pathways. Psychosom. Med. 62:2000;591-598.
12. Heyes M. P., Chen C. Y., Major E. O., Saito K. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem. J. 326:1997;351-356.
13. LeMay L. G., Vander A. J., Kluger M. J. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav. 47:1990;957-961.
14. Maes M., Verkerk R., Delmeire L., Van Gastel A., van Hunsel F., Scharpe S. Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia. Psychiatry Res. 97:2000;11-20.
15. Moldofsky H. Rheumatic pain modulation syndrome: The interrelationships between sleep, central nervous system serotonin, and pain. Adv. Neurol. 33:1982;51-57.
16. Moreno F. A., McGavin C., Malan T. P., Gelenberg A. J., Heninger G. R., Mathe A. A., Delgado P. L. Tryptophan depletion selectively reduces CSF 5-HT metabolites in healthy young men: Results from single lumbar puncture sampling technique. Int. J. Neuropsychopharmacol. 3:2000;277-283.
17. Moroni F. Tryptophan metabolism and brain function: Focus on kynurenine and other indole metabolites. Eur. J. Pharmacol. 375:1999;87-100.
18. Neumeister A., Turner E. H., Matthews J. R., Postolache T. T., Barnett R. L., Rauh M., Vetticad R. G., Kasper S., Rosenthal N. E. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch. Gen. Psychiatry. 55:1998;524-530.
19. Nishizawa S., Benkelfat C., Young S. N., Leyton M., Mzengeza S., de Montigny C., Blier P., Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. USA. 94:1997;5308-5313.
20. Ravindran A. V., Griffiths J., Merali Z., Knott V. J., Anisman H. Influence of acute tryptophan depletion on mood and immune measures in healthy males. Psychoneuroendocrinology. 24:1999;99-113.
21. Russell I. J. Neurochemical pathogenesis of fibromyalgia syndrome. J. Musculosceletal Pain. 4:1996;61-92.
22. Russell I. J., Michalek J. E., Vipraio G. A., Fletcher E. M., Javors M. A., Bowden C. A. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome [see comments]. J. Rheumatol. 19:1992b;104-109.
23. Russell I. J., Vaeroy H., Javors M., Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis [see comments]. Arthritis. Rheum. 35:1992a;550-556.
24. Schwarz M. J., Spaeth M., Müller-Bardorff H., Pongratz D., Bondy B., Ackenheil M. Relationship of substance P, 5-hydroxyindoleacetic acid and tryptophan in serum of fibromyalgia patients. Neurosci. Lett. 259:1999;196-198.
25. Sicuteri F. Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity). Headache. 12:1972;69-72.
26. Stancampiano R., Melis F., Sarais L., Cocco S., Cugusi C., Fadda F. Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. Am. J. Physiol. 272:1997;R991-R994.
27. Stastny J., Konstantinidis A., Schwarz M. J., Rosenthal N. E., Vitouch O., Kasper S., Neumeister A. Effects of tryptophan depletion and catecholamine depletion on immune parameters in patients with seasonal affective disorder in remission with light therapy. Biol. Psychiat. 2002.
28. Steptoe A., Willemsen G., Owen N., Flower L., Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin. Sci.(Lond.). 101:2001;185-192.
29. Stratz T., Samborski W., Hrycaj P., Pap T., Mackiewicz S., Mennet P., Muller W. [Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis]. Med. Klin. 88:1993;458-462.
30. Wallace D. J., Linker-Israeli M., Hallegua D., Silverman S., Silver D., Weisman M. H. Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumatology.(Oxford). 40:2001;743-749.
31. Williams W. A., Shoaf S. E., Hommer D., Rawlings R., Linnoila M. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J. Neurochem. 72:1999;1641-1647.
32. Wolfe F., Ross K., Anderson J., Russell I. J. Aspects of fibromyalgia in the general population: Sex, pain threshold, and fibromyalgia symptoms. J. Rheumatol. 22:1995a;151-156.
33. Wolfe F., Ross K., Anderson J., Russell I. J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis. Rheum. 38:1995b;19-28.
34. Wolfe F., Russell I. J., Vipraio G., Ross K., Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J. Rheumatol. 24:1997;555-559.
35. Wolfe F., Smythe H. A., Yunus M. B., Bennett R. M., Bombardier C., Goldenberg D. L., Tugwell P., Campbell S. M., Abeles M., Clark P., Fam A. G., Farber S. J., Fiechtner J. J., Franklin C. M., Gatter R. A., Hamaty D., Lessrad J., Lichtbroun A. S., Masi A. T., McCain G. A., Reynolds W. J., Romano T. J., Russell I. J., Sheon R. P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee [see comments]. Arthritis. Rheum. 33:1990;160-172.
36. Zhou D., Kusnecov A. W., Shurin M. R., DePaoli M., Rabin B. S. Exposure to physical and psychological stressors elevates plasma interleukin 6: Relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 133:1993;2523-2530.